Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria
US5179018A · kind A · utility
19Cited by
4References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 14, 1983 |
| Grant date | Jan 12, 1993 |
| Priority date | — |
| Expiry date | Oct 14, 2003 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/865
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Mammalian monoclonal anti-lipopolysaccharide (LPS) antibodies which react with gram-negative bacteria across different genera are disclosed. The anti-LPS antibodies are useful for the treatment or prevention of gram-negative bacteremia and for the detection of gram-negative microorganisms.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.